1 |
Giuffrè M, Gazzin S, Zoratti C, Llido JP, Lanza G, Tiribelli C, Moretti R. Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation. Int J Mol Sci 2022;23. [PMID: 36555205 DOI: 10.3390/ijms232415564] [Reference Citation Analysis]
|
2 |
E Abdelaziz H, El-Guendy N, Radwan EM, Sharawi SK, El-Houseini ME, Abdel-Wahab AA. Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients. Asian Pac J Cancer Prev 2022;23:4125-35. [PMID: 36579994 DOI: 10.31557/APJCP.2022.23.12.4125] [Reference Citation Analysis]
|
3 |
Li D, Zhao X, Pi X, Wang K, Song D. Systemic immune-inflammation index and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta-analysis. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00889-y] [Reference Citation Analysis]
|
4 |
Giuffrè M, Zuliani E, Visintin A, Tarchi P, Martingano P, Pizzolato R, Bonazza D, Masutti F, Moretti R, Crocè LS; Liver Multidisciplinary Group of Trieste. Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center Experience. Diagnostics (Basel) 2022;12. [PMID: 36292205 DOI: 10.3390/diagnostics12102517] [Reference Citation Analysis]
|